| 2021 |
Pratt, N. L., Ellett, L. M. K., Andrade, A. Q., Le Blanc, V. T., Barratt, J., & Roughead, E. E. (2021). Prevalence of multiple risk factors for poor outcomes associated with COVID-19 among an elderly Australian population. Australian Journal of General Practice, 50(1-2), 84-89.
DOI Scopus4 WoS3 Europe PMC3 |
| 2020 |
Andrade, A. Q., LeBlanc, V. T., Kalisch Ellett, L. M., Pratt, N. L., Moffat, A., Blacker, N., . . . Roughead, E. E. (2020). Determinants of usefulness in professional behaviour change interventions: observational study of a 15-year national program. BMJ open, 10(10), 1-8.
DOI Scopus3 WoS4 Europe PMC3 |
| 2020 |
Pratt, N. L., Kerr, M., & Barratt, J. D. (2020). The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification System (vol 8, e021122, 2018). BMJ OPEN, 10(9), 1 page.
DOI WoS3 |
| 2019 |
Caughey, G. E., Shakib, S., Barratt, J. D., & Roughead, E. E. (2019). Use of medicines that may exacerbate heart failure in older adults: therapeutic complexity of multimorbidity. Drugs and Aging, 36(5), 471-479.
DOI Scopus10 WoS11 Europe PMC9 |
| 2018 |
Pratt, N., Kerr, M., Barratt, J., Kemp Casey, A., Kalisch Ellett, L., Ramsay, E., & Roughead, E. (2018). The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification System. BMJ open, 8(4), 1-8.
DOI Scopus227 WoS231 Europe PMC195 |
| 2018 |
Kalisch Ellett, L. M., Pratt, N. L., Sluggett, J. K., Ramsay, E. N., Kerr, M., LeBlanc, V. T., . . . Roughead, E. E. (2018). Sustaining practice change in health care: the impact of a national quality improvement program on the uptake of collaborative medicines reviews. Journal of pharmacy practice and research, 48(3), 222-230.
DOI Scopus7 |
| 2018 |
Kalisch Ellett, L. M., Lim, R., Pratt, N. L., Kerr, M., Ramsay, E. N., Leblanc, T. V., . . . Roughead, E. E. (2018). Reducing hypnotic use in insomnia management among Australian veterans: Results from repeated national interventions. BMC Health Services Research, 18(1), 626.
DOI Scopus4 WoS4 Europe PMC4 |
| 2017 |
Caughey, G., Kalisch Ellett, L., Barratt, J., & Shakib, S. (2017). Apixaban, concomitant medicines and spontaneous reports of haemorrhagic events. Therapeutic Advances in Drug Safety, 8(5), 157-164.
DOI Scopus8 WoS7 Europe PMC5 |
| 2017 |
Kalisch Ellett, L. M., Pratt, N. L., Sluggett, J. K., Ramsay, E. N., Kerr, M., LeBlanc, V. T., . . . Roughead, E. E. (2017). Patient-specific prescriber feedback can increase the rate of osteoporosis screening and treatment: results from two national interventions. Archives of osteoporosis, 12(1, article no. 17), 1-7.
DOI Scopus6 WoS6 Europe PMC5 |
| 2017 |
Roughead, E. E., Pratt, N. L., Kalisch Ellett, L. M., Ramsay, E. N., Barratt, J. D., Morris, P., & Killer, G. (2017). Posttraumatic Stress Disorder, Antipsychotic Use and Risk of Dementia in Veterans. Journal of the American Geriatrics Society, 65(7), 1521-1526.
DOI Scopus20 WoS20 Europe PMC17 |
| 2017 |
Pratt, N. L., Kalisch Ellett, L. M., Sluggett, J. K., Gadzhanova, S. V., Ramsay, E. N., Kerr, M., . . . Roughead, E. E. (2017). Use of proton pump inhibitors among older Australians: National quality improvement programmes have led to sustained practice change. International Journal for Quality in Health Care, 29(1), 75-82.
DOI Scopus27 WoS21 Europe PMC22 |
| 2017 |
Caughey, G. E., Barratt, J. D., Shakib, S., Kemp-Casey, A., & Roughead, E. E. (2017). Medication use and potentially high-risk prescribing in older patients hospitalized for diabetes: a missed opportunity to improve care?. Diabetic Medicine, 34(3), 432-439.
DOI Scopus17 WoS15 Europe PMC12 |
| 2017 |
Caughey, G., Pratt, N., Barratt, J., Shakib, S., Kemp-Casey, A., & Roughead, E. (2017). Understanding 30-day re-admission after hospitalisation of older patients for diabetes: Identifying those at greatest risk. Medical Journal of Australia, 206(4), 170-175.
DOI Scopus26 WoS24 Europe PMC19 |
| 2016 |
Kalisch Ellett, L. M., Pratt, N. L., Ramsay, E. N., Sluggett, J. K., Barratt, J. D., & Roughead, E. E. (2016). Central Nervous System-Acting Medicines and Risk of Hospital Admission for Confusion, Delirium, or Dementia. Journal of the American Medical Directors Association, 17(6), 530-534.
DOI Scopus9 WoS9 Europe PMC7 |
| 2015 |
Kalisch Ellett, L. M., Pratt, N. L., Ramsay, E. N., Barratt, J. D., & Roughead, E. E. (2015). Response to lertxundi and colleagues. Journal of the American geriatrics society, 63(5), 1054-1055.
DOI |
| 2015 |
Pratt, N. L., Kalisch Ellett, L. M., Sluggett, J. K., Ramsay, E. N., Kerr, M., LeBlanc, V. T., . . . Roughead, E. E. (2015). Commitment questions targeting patients promotes uptake of under-used health services: findings from a national quality improvement program in Australia. Social Science and Medicine, 145, 1-6.
DOI Scopus6 WoS6 Europe PMC6 |
| 2015 |
Mcdonald, C., Kalisch Ellett, L., Barratt, J., & Caughey, G. (2015). An international comparison of spontaneous adverse event reports and potentially inappropriate medicine use associated with dabigatran. Pharmacoepidemiology and Drug Safety, 24(4), 399-405.
DOI Scopus23 WoS21 Europe PMC20 |
| 2015 |
Ellett, L. M. K., Pratt, N. L., Ramsay, E. N., Barratt, J. D., & Roughead, E. E. (2015). Re: Multiple Anticholinergic Medication Use and Risk of Hospital Admission for Confusion or Dementia Editorial Comment. JOURNAL OF UROLOGY, 194(5), 1353.
DOI |
| 2014 |
McDonald, C., Kalisch Ellett, L., Barratt, J., & Caughey, G. (2014). A cross-country comparison of rivaroxaban spontaneous adverse event reports and concomitant medicine use with the potential to increase the risk of harm. Drug Safety, 37(12), 1029-1035.
DOI Scopus16 WoS15 Europe PMC13 |
| 2014 |
Kalisch Ellett, L. M., Pratt, N. L., Ramsay, E. N., Barratt, J. D., & Roughead, E. E. (2014). Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia. Journal of the American Geriatric Society, 62(10), 1916-1922.
DOI Scopus105 WoS88 Europe PMC78 |
| 2014 |
Pratt, N. L., Ramsay, E. N., Kalisch Ellett, L. M., Nguyen, T. A., Barratt, J. D., & Roughead, E. E. (2014). Association between use of multiple psychoactive medicines and hospitalization for falls : retrospective analysis of a large healthcare claim database. Drug safety, 37(7), 529-535.
DOI Scopus35 WoS33 Europe PMC28 |
| 2014 |
Kalisch Ellett, L. M., Pratt, N. L., Barratt, J. D., Rowett, D., & Roughead, E. E. (2014). Risk of medication-associated initiation of oxybutynin in elderly men and women. Journal of the American Geriatrics Society, 62(4), 690-695.
DOI Scopus22 WoS20 Europe PMC16 |
| 2013 |
Roughead, E., Kalisch Ellett, L., Ramsay, E., Pratt, N., Barratt, J., LeBlanc, V., . . . Gilbert, A. (2013). Bridging evidence-practice gaps: improving use of medicines in elderly Australian veterans. BMC Health Services Research, 13(article no. 514), 1-14.
DOI Scopus29 WoS28 Europe PMC25 |
| 2013 |
Kalisch Ellett, L. M., Pratt, N. L., Barratt, J. D., & Roughead, E. E. (2013). Urinary incontinence: a poorly recognised adverse effect of medicines. Pharmacoepidemiology and drug safety, 22(s1, article no. 948), 475. |
| 2013 |
Kalisch Ellett, L. M., Ramsay, E. N., Barratt, J. D., Gilbert, A. L., & Roughead, E. E. (2013). Home medicines reviews: extent of uptake by high-risk veterans. Journal of pharmacy practice and research, 43(3), 182-186.
DOI Scopus9 |
| 2012 |
Kalisch, L., Caughey, G., Barratt, J., Ramsay, E., Killer, G., Gilbert, A., & Roughead, E. (2012). Prevalence of preventable medication-related hospitalizations in Australia: An opportunity to reduce harm. International Journal for Quality in Health Care, 24(3), 239-249.
DOI Scopus63 WoS53 Europe PMC47 |
| 2011 |
Roughead, E., Barratt, J., Ramsay, E., Pratt, N., Ryan, P., Peck, R., . . . Gilbert, A. (2011). Collaborative home medicines review delays time to next hospitalization for warfarin associated bleeding in Australian war veterans. Journal of Clinical Pharmacy and Therapeutics, 36(1), 27-32.
DOI Scopus52 WoS39 Europe PMC31 |
| 2011 |
Bell, J. S., Kalisch Ellett, L. M., Ramsay, E. N., Pratt, N. L., Barratt, J. D., Le, B. T., . . . Gilbert, A. L. (2011). Prescriber feedback to improve quality use of medicines among older people: the veterans' MATES program. Journal of pharmacy practice and research, 41(4), 316-319.
DOI Scopus13 |
| 2011 |
Lu, C. Y., Barratt, J., Vitry, A., & Roughead, E. (2011). Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting. Journal of clinical epidemiology, 64(2), 223-228.
DOI Scopus88 WoS84 Europe PMC76 |
| 2010 |
Roughead, E. E., Kalisch Ellett, L. M., Barratt, J. D., & Gilbert, A. L. (2010). Prevalence of potentially hazardous drug interactions amongst Australian veterans. British journal of clinical pharmacology, 70(2), 252-257.
DOI Scopus57 WoS43 Europe PMC38 |
| 2010 |
Roughead, E., Vitry, A., Preiss, A., Barratt, J., Gilbert, A., & Ryan, P. (2010). Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular disease. European Journal of Cardiovascular Prevention ' Rehabilitation, 17(1), 71-76.
DOI Scopus13 WoS13 Europe PMC11 |
| 2009 |
Roughead, E., Barratt, J., Ramsay, E., Pratt, N., Ryan, P., Peck, R., . . . Gilbert, A. (2009). The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study. Circulation. Heart Failure, 2(5), 424-428.
DOI Scopus121 WoS90 Europe PMC77 |
| 2009 |
Vitry, A., Wong, S., Roughead, E., Ramsay, E., & Barratt, J. (2009). Validity of medication-based co-morbidity indices in the Australian elderly population. Australian and New Zealand Journal of Public Health, 33(2), 126-130.
DOI Scopus94 WoS89 Europe PMC77 |
| 2009 |
Roughead, E., Ramsay, E., Priess, K., Barratt, J., Ryan, P., & Gilbert, A. (2009). Medication adherence, first episode duration, overall duration and time without therapy: the example of bisphosphonates. Pharmacoepidemiology and Drug Safety, 18(1), 69-75.
DOI Scopus17 WoS15 Europe PMC15 |
| 2009 |
Gilbert, A. L., Roughead, E. E., Barratt, J. D., Ramsey, E., Pratt, N., Ryan, P., . . . Killer, G. (2009). The Effectiveness of Collaborative Medicine Reviews in Delaying Time to Next Hospitalisation for Heart Failure Patients in the Ambulatory Setting: Results of a Cohort Study. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 18, S122. |
| 2008 |
Roughead, E. E., Barratt, J. D., Gilbert, A. L., Peck, R., & Killer, G. (2008). Diabetes processes of care in the Australian veteran population. Diabetes research and clinical practice, 79(2), 299-304.
DOI Scopus7 WoS7 Europe PMC7 |
| 2004 |
Roughead, E. E., Barratt, J. D., & Gilbert, A. L. (2004). Medication-related problems commonly occurring in an Australian community setting. Pharmacoepidemiology and drug safety, 13(2), 83-87.
DOI Scopus72 WoS60 Europe PMC54 |
| 2002 |
Gilbert, A. L., Roughead, E. E., Beilby, J., Mott, K., & Barratt, J. D. (2002). Collaborative medication management services. Medical journal of Australia. |
| 2002 |
Gilbert, A., Roughead, E., Beilby, J., Mott, K., & Barratt, J. (2002). Collaborative medication management services: improving patient care. Medical Journal of Australia, 177(4), 189-192.
DOI Scopus131 WoS96 Europe PMC86 |
Available For Media Comment.